The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Induction chemotherapy with weekly cetuximab, carboplatin, and paclitaxel in the treatment of locally advanced head and neck cancer: The University of Pennsylvania experience.
Jessica R Bauman
No relevant relationships to disclose
Corey J. Langer
Consultant or Advisory Role - Bristol-Myers Squibb; ImClone Systems; Lilly
Harry Quon
No relevant relationships to disclose
Kenneth M. Algazy
No relevant relationships to disclose
Arati Suvas Desai
No relevant relationships to disclose
Faith Mutale
No relevant relationships to disclose
Alexander Lin
No relevant relationships to disclose
Jared Weiss
No relevant relationships to disclose